NeoClone Biotechnology awarded $250K for ovarian cancer test
The federal government has awarded two more Small Business Innovation Research grants to NeoClone Biotechnology for its work in developing antibody microarray tests that could improve the detection of ovarian cancer. The grants, awarded by the National Cancer Institute, total $250,000. ...